Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Actinogen Medical Limited ( (AU:ACW) ) has provided an announcement.
Actinogen Medical Limited has announced the application for the quotation of new securities to be listed on the Australian Securities Exchange (ASX). This move indicates an expansion in the company’s financial activities, potentially enhancing its capital and positioning within the biotechnology industry.
More about Actinogen Medical Limited
Actinogen Medical Limited operates in the biotechnology industry, focusing on the development of innovative therapeutics. The company primarily targets neurological diseases and disorders, aiming to address unmet medical needs in this sector.
YTD Price Performance: 2400.0%
Average Trading Volume: 810,100
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $52.71M
For a thorough assessment of ACW stock, go to TipRanks’ Stock Analysis page.